Table 3 The derivation of the patients status on the last day of follow, which is required for survival analysis
From: World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Key Variable | Status | |||||
|---|---|---|---|---|---|---|
Species at Enrollment * | Outcome † | Species at Failure * | PCR Correction ** | PF Unadjusted by genotyping φ | PF Recrudescence φ | PV Recurrence φ |
1–5 | 0 | N/A | N/A | 0 | 0 | 0 |
Any | 1–6 | 1 | N/A | 1 | 1 | 0 |
Any | 1–6 | 2 | N/A | 0 | 0 | 1 |
1 or 3 or 4 | 7–12 | 1 or 4 | 1 | 1 | 0 | 0 |
1 or 3 or 4 | 7–12 | 1 or 4 | 2 | 1 | 1 | 0 |
1 or 3 or 4 | 7–12 | 1 or 4 | 3 | 1 | § | 0 |
1 or 3 or 4 | 7–12 | 3 | 1 | 1 | 0 | 1 |
1 or 3 or 4 | 7–12 | 3 | 2 | 1 | 1 | 1 |
1 or 3 or 4 | 7–12 | 3 | 3 | 1 | § | 1 |
1 or 3 or 4 | 7–12 | 2 or 5 | N/A | 0 | 0 | 1 |
1 or 3 or 4 | 7–12 | 6 | N/A | 0 | 0 | 0 |
2 or 5 | 7–12 | 1 or 4 | N/A | 1 | - | 0 |
2 or 5 | 7–12 | 3 | N/A | 1 | - | 1 |
2 or 5 | 7–12 | 2 or 5 | N/A | 0 | - | 1 |
2 or 5 | 7–12 | 6 | N/A | 0 | - | 0 |
1–5 | 13–20 | N/A | N/A | 0 | 0 | 0 |
1–5 | 21 | N/A | N/A | - | - | - |